Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
Oral sex spreading unstoppable bacteria

Oral sex is producing dangerous gonorrhoea and a decline in condom use is helping it to spread, the World Health Organization has said. Gonorrhoea can infect the genitals, rectum and throat, but it is the last that is most concerning health officials. Dr Wi said antibiotics could lead to bacteria in the back of the throat, including relatives of gonorrhoea, developing resistance. She said: "When you use antibiotics to treat infections like a normal sore throat, this mixes with the Neisseria species in your throat and this results in resistance."

Published
07 July 2017
From
BBC
Viral load as low as 400 copies/ml six months after starting ART is associated with a significant ten-year mortality risk

A viral load as low as 400 copies/ml six months after starting HIV therapy is associated with a substantial ten-year mortality risk, investigators from the

Published
05 July 2017
By
Michael Carter
Why are women lost from HIV care during pregnancy? Malawi study shows social support and counselling are critical

Lack of social support after diagnosis and inadequate counselling about HIV treatment and HIV disclosure were identified as key reasons for dropping out of HIV

Published
28 June 2017
By
Keith Alcorn
Kenya to introduce better treatment for people living with HIV

To accelerate access to better antiretroviral (ARV) drugs, the Government of Kenya and Unitaid today announced the introduction of dolutegravir, a new first-line drug for people living with HIV, making Kenya the first African country to introduce the generic version of this new drug for routine use.

Published
28 June 2017
From
UNITAID
HIV drug resistance becoming more common in Zambian infants

The proportion of infants with HIV who had drug resistance at the time of HIV diagnosis almost doubled in Zambia between 2009 and 2014 despite

Published
27 June 2017
By
Keith Alcorn
Dolutegavir access in the Asia-Pacific region

This factsheet provides information on the use of dolutegravir in HIV treatment and access to dolutegravir under Medicines Patent Pool voluntaray licenses.

Published
27 June 2017
From
amfAR Treat Asia
Last Gift Study: Community Perspective on End-of-Life HIV Research

In the second of this 3-part series, Sara Gianella Weibel, MD, on behalf of Infectious Disease Advisor, talks with Jeff Taylor, community activist and long-term HIV survivor, about ethical concerns and practical barriers in end-of-life research and how the HIV community will embrace this type of research.

Published
21 June 2017
From
Infectious Disease Advisor
Last Gift Study: End-of-Life HIV Research

Few opportunities currently exist for terminally ill people to participate in HIV research as a result of various cultural taboos and ethical concerns, such as exploitation, vulnerability, and coercion. However, when faced with their approaching death, some individuals may be willing to participate in research that offers no hope for their condition to leave a final gift to their community.

Published
21 June 2017
From
Infectious Disease Advisor
Medicine information leaflets 'too scary', say experts

A more balanced view of the benefits and potential side effects is being called for in a report.

Published
20 June 2017
From
BBC Health
Understanding HIV's persistence

A new study, published in the Journal of Clinical Investigation, led by Mathias Lichterfeld, MD, PhD, and Guinevere Lee, PhD, from the Brigham and Women's Hospital Infectious Disease Division sheds new light on the mechanism underlying the persistence of HIV-1 infected cells despite antiviral treatment. "Our research points to a driving force that stabilizes the pool of HIV-infected cells in the host, which can persist lifelong despite very effective antiretroviral therapy," said Lichterfeld.

Published
20 June 2017
From
EurekAlert (press release)

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.